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Consumer Willingness to Pay for GM Food 
Benefits: Pay-off or Empty Promise? 
Implications for the Food Industry
by Benjamin Onyango and Ramu Govindasamy
The Promise of Ag-Biotech
The biotechnology industry has spent substantial money
researching and developing genetically modified (GM)
products with tangible consumer benefits. The potential
benefits include longer shelf stability, enhanced sensory
appeal, reduced allergenicity, and nutritional or wellness
attributes (Riley & Hoffman, 1999; Feldman et al., 2000).
It is understandable that these distinct consumer GM food
products’ benefits (which are not available in the non-GM
products) are likely to be critically important for broad
consumer acceptance. However, as GM food products
with enhanced and functional attributes appear in the
marketplace, consumers will be faced with the choice
between GM products bringing tangible benefits (but car-
rying unknown risks) and the traditional non-GM prod-
ucts that do not provide distinct and tangible consumer
benefits. 
It is important that researchers contribute to the ongo-
ing discourse over benefits and risks of biotechnology by
providing scientifically credible information on how con-
sumers value various food attributes, including process
attributes such as genetic modification. This is especially
true given that food consumption in the United States and
other developed countries is driven by factors other than
physiological need. The majority of consumers in these
countries want foods that are not only safe, but also pro-
mote good health and overall well being (Senauer, 2001).
This study contributes to the ongoing debate over food
biotechnology by explicitly modeling how consumers
trade-off the potential or perceived risks of GM foods with
the possibility of extracting significant benefits from GM
foods. 
In particular, this study analyzes (i) how consumers
value the attributes embodied in food products (e.g., pro-
duction technology, product benefit); (ii) how consumer
valuation of these attributes vary across product types
(e.g., whether it is consumed as a fresh product, a pro-
cessed product, an animal-based product); and (iii) how
the preferences over product attribute and product type
combinations are influenced by the consumer demograph-
ics.
Understanding the values consumers place on individ-
ual product attributes may provide insights for the food
industry in tailoring targeted marketing product strategies
in line with changing consumer demands. The study
results may also help policy makers decide which potential
benefits of genetic modification are viable and acceptable
to consumers. 
Data and Modeling Framework
Data used in this analysis were obtained from mail inter-
views of respondents recruited at the end of a national
telephone survey conducted and completed between Feb-
ruary 27, 2003 and April 1, 2003. The mail survey elicited
consumers’ stated preference for the GM foods. Those
participating in the mail survey received a five-dollar
incentive for their effort. A total of 661 participated in the
mail survey with 409 (61.9%) returning completed sur-
veys distributed as follows: bananas: 137; cornflakes: 128;
and ground beef: 144.
Before fielding the choice modeling mail survey, the
experimental design was subjected to several lengthy dis-
cussions by various groups, comprised of life and social
scientists. This facilitated decisions on the appropriateness
of products that may appeal to the larger public, with
potential and likely attributes and plausible genetic modi-
fication technologies through which the products could be224 CHOICES 4th Quarter 2005 • 20(4)
delivered. The products chosen were
either whole (fresh), processed; or
animal-based. In terms of benefits,
care was taken to incorporate benefits
that could broadly impact a con-
sumer’s health, have some type of
consumer benefit, or provide a "soci-
etal" benefit. While in the case of
technologies, the strategy was incor-
porating a wide range of existing and
potential technologies such as plant
or animal-based genes or micro-
organisms (bacterium).
Consumer preferences over food
attributes are analyzed within the
random utility discrete choice model
framework (McFadden, 1978; Rev-
elt and Train, 1998). Since market
data from GM food products are not
available, stated preferences (SP)
choice modeling framework (Lou-
viere, Hensher, & Swait, 2000) is
used. The empirical model (i.e., the
random parameter model) was esti-
mated to obtain respondents' valua-
tion of the benefits and the technolo-
gies jointly. The analysis involved
examination of potential industry
products in very specific details.
Whose advantage was in terms of
respondents' ability to relate to spe-
cific product characteristics based on
carefully thought out answers. For
example, corn flakes with longer shelf
life versus corn flakes that stay crispy
in milk longer or a banana that does
not often bruise as quickly. 
Consumer Stated Preferences
The willingness to pay/accept values
was estimated by evaluating the ratio
of the attribute coefficient (benefit or
technology) to the coefficient of the
monetary variable. Ceteris paribus,
implicit prices were obtained that
represent marginal rates of substitu-
tion between the attribute of interest
(technology and benefit) and the
monetary attribute. The positive val-
ues imply changes were beneficial
(i.e., a consumer was willing to pay a
positive amount for an increase of the
attribute), while negative values
implied reduction in utility (i.e., the
consumer required compensation
which may be in the form of a price
discount for a unit increase in the
attribute in this case the value may be
taken to measure willingness to
accept (WTA)). In reality, when con-
sumers are presented with actual
choices of GM products, stated pref-
erences may be different from the
actual buying behavior.
Figures 1-3 present the mean
willingness to pay for bananas, corn-
flakes, and ground beef. Most of the
benefits across the three products
have a positive effect on choice across
the three products. The exception is
antioxidants in the banana and added
nutrients for stronger teeth and
bones in ground beef that were insig-
nificant. The significant and positive
product benefits have a welfare
 
Figure 1. Willingness to pay: banana.
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improving effect on a genetically
modified food choice. The negative
coefficients on genetic modification
technology imply that moving from
the conventional food production
technology reduces the probability of
selection as that may lead to overall
reduction in a consumer’s utility.
Conversely, a positive coefficient on a
technology leads to an increase of
utility. When ground beef was a
product of cows fed on GM corn and
a banana was modified using its own
genes, in this case technology served
to enhance consumer utility. Genetic
modification involving animal genes,
Bacterium, and plant genes has a
negative effect on choice (i.e., reduces
the probability of the GM alternative
being selected).
Bananas
In the case of the banana (a fresh
fruit or vegetable product), posi-
tively associated benefits were: use of
less pesticides and chemicals to grow
bananas, and increased shelf life (i.e.,
a banana that stays riper longer and
reduces bruising). Respondents were
willing to pay about 3% more com-
pared to the current price in order to
obtain such benefits. On the other
hand, in case of technology; if the
banana product is a result of genetic
modification via plant, animal, or
bacterium genes, the respondents
needed to be compensated to accept
it. The results show that more com-
pensation is required to induce
acceptance of processes involving ani-
mal, bacterium, and plant genes
(22%, 9%, and 5%, respectively).
Conversely, if the GM banana was a
result of own gene transfer, consum-
ers were willing to pay 3% more for
the product. The results also show
that respondents ranked technology
from least to more acceptable (i.e.,
moving from a small to a larger nega-
tive and vice-versa). They ranked
genetic modification via own genes
t o p ,  f o l l o w e d  b y  p l a n t ,  w i t h  b a c t e -
rium and animal-based technologies
at the bottom. Given the normality
assumption, at the same price, about
32-35% of the respondents would
have placed a negative valuation of
less pesticide use, added antioxidants,
and a banana that ripens longer.
Unlike the benefits, respondents
largely placed negative valuation on
technologies, ranging from 63-84%.
Cornflakes
I n  c a s e  o f  c o r n f l a k e s  ( a  p r o c e s s e d
product), respondents valued all the
benefits positively. The benefits
included: less chemicals/pesticides in
corn production, added antioxidants
to reduce aging, and added com-
pounds for increased energy. How-
ever, given the normal distribution
assumption, about 18-40% of the
respondents could have valued these
benefits negatively. Results indicate
that respondents were willing to pay
between 5% and 19% more to
obtain the direct health and environ-
mentally related benefit of corn pro-
duced with less pesticides and chemi-
cals. Unlike the case of benefits,
respondents largely placed a negative
valuation on technologies ranging
from 47-81%. As a result, if the
cornflakes are genetically modified
using plant, bacterium and animal
genes, consumers need to be com-
pensated by about 10-37% more to
accept the cornflakes. 
Ground Beef
For ground beef (animal-based prod-
uct), with the exception of added
compounds for stronger teeth and
bones which turned out to be insig-
nificant, consumers were willing to
pay 2% more to obtain the benefits
of less antibiotics in cow production
and 3% more for antioxidants to
slow down the aging process. In con-
trast, consumers required a compen-
sation to accept ground beef, which
was a product of genetic modifica-
tion involving animal or bacterium
genes (20% and 13%, respectively).
However, if the ground beef was a
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product of a cow fed on GM corn,
consumers were willing to pay 6%
more. With the normality assump-
tion, at the same price, about 52-
62% of the respondents placed a pos-
itive valuation on fewer antibiotics
and antioxidants. On the other hand,
compared to cornflakes and bananas,
fewer respondents placed a positive
coefficient on technology ranging
from 19-60%.
Implications for Food Industry
The study results show that the use of
choice modeling experiments pro-
vides a way of valuing non monetary
attributes associated with consump-
tion of GM food products and a way
of identifying consumer preferences.
The results indicate how different
attributes of price, product benefits,
and technology influence consumer
demand for genetically modified
food products. The results show how
a consumer makes tradeoffs between
the product attributes. 
The results suggest that across the
products, direct health, environmen-
tal and production-related benefits
have a positive effect on choice. Also,
the results generally show that
genetic modification is viewed nega-
tively. However, through the choice
modeling experiments, respondents
viewed own- and plant-based genetic
modification less negatively than the
use of bacterium and animal-based
genetic modification. These results
may suggest that attitudes may be
somehow more promising for GM
processes involving own- or plant-
based gene technology. Respondents’
willingness to pay for benefits
embedded in the products suggests
that there is potential for GM foods
in the market.
Understanding the values con-
sumers place on individual attributes
can provide insights for the food
industry in tailoring targeted market-
ing product strategies in line with
changing consumer demands. The
study results also provide informa-
tion to policy makers on which direc-
tion to go in terms of genetic modifi-
cation (i.e., what is viable and
acceptable). 
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